Graft function 1 year after pregnancy in an islet-transplanted patient

Transpl Int. 2015 Oct;28(10):1235-9. doi: 10.1111/tri.12596. Epub 2015 May 11.

Abstract

Pancreatic islet transplantation is a treatment option for patients with type 1 diabetes (T1D), but pregnancy has generally not been advised for women after receiving an islet allograft. We hereby describe what is to our knowledge the first successful pregnancy and persistent graft function in a woman 4 years after her initial islet transplantation. A 37-year-old woman with brittle type 1 diabetes was transplanted with two separate islet graft infusions, eventually becoming insulin independent. Ten months after her second transplantation, her immunosuppression was switched from tacrolimus and sirolimus to tacrolimus, azathioprine, and prednisolone, due to her wish to become pregnant. She became pregnant one year later, and after 38 weeks of uncomplicated pregnancy, she gave birth to a healthy child by C-section. The current report suggests that pregnancy and childbirth can be accomplished after islet transplantation without loss of islet graft function.

Keywords: glucocorticoids; islet transplantation; pregnancy; type 1 diabetes.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • C-Peptide / blood
  • Cesarean Section
  • Diabetes Mellitus, Type 1 / surgery
  • Drug Substitution
  • Drug Therapy, Combination
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Infant, Newborn
  • Islets of Langerhans / physiology*
  • Islets of Langerhans Transplantation*
  • Pregnancy
  • Pregnancy Complications
  • Reoperation
  • Transplants / physiology

Substances

  • C-Peptide
  • Immunosuppressive Agents